Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Amlot

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1987
The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineageD Campana, J S Thompson, P Amlot, et al.
The Journal of Pathology|June 1, 1993
Protection of germinal centres from complement attack: decay-accelerating factor (DAF) is a constitutive protein on follicular dendritic cells. A study in reactive and neoplastic folliclesI A Lampert, J B Schofield, P Amlot, et al.
Leukemia Research|January 1, 1989
T-cell receptor gene rearrangement in B-cell non-Hodgkin's lymphoma: correlation with methylation and expressionB F Leber, P Amlot, A V Hoffbrand, et al.
European Journal of Haematology|April 1, 1989
Rearrangement of TCR gamma chain gene involving JP1 suggests early thymocyte origin of peripheral T-cell lymphomaB F Leber, P Amlot, A V Hoffbrand, et al.
Leukemia|July 1, 1994
Variable kappa gene rearrangement in lymphoproliferative disorders: an analysis of V kappa gene usage, VJ joining and somatic mutationP K Cannell, P Amlot, M Attard, et al.
Biochemical Society Transactions|May 1, 1997
Recombinant RFB4 single-chain immunotoxin that is cytotoxic towards CD22-positive cellsE Mansfield, M F Chiron, P Amlot, et al.
International Journal of Cancer|September 30, 1991
Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in miceA Engert, G Martin, P Amlot, et al.
Journal of Clinical & Laboratory Immunology|September 1, 1984
A single step radial immunodiffusion (RID) method for the quantitation of monomeric IgMR J Coughlan, A Faith, G S Panayi, et al.
The New England Journal of Medicine|December 1, 1983
Case 15-1983: Hodgkin's disease and focal glomerulosclerosisM Phillips, G H Neild, J S Cameron, et al.
Clinical and Laboratory Haematology|October 16, 2004
Subacute immune response to primary EBV infection leading to post-transplant lymphoproliferative disease in a renal transplant patientS Leaver, P Amlot, R Thuraisingham, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1987
The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineageD Campana, J S Thompson, P Amlot, et al.
The Journal of Pathology|June 1, 1993
Protection of germinal centres from complement attack: decay-accelerating factor (DAF) is a constitutive protein on follicular dendritic cells. A study in reactive and neoplastic folliclesI A Lampert, J B Schofield, P Amlot, et al.
Leukemia Research|January 1, 1989
T-cell receptor gene rearrangement in B-cell non-Hodgkin's lymphoma: correlation with methylation and expressionB F Leber, P Amlot, A V Hoffbrand, et al.
European Journal of Haematology|April 1, 1989
Rearrangement of TCR gamma chain gene involving JP1 suggests early thymocyte origin of peripheral T-cell lymphomaB F Leber, P Amlot, A V Hoffbrand, et al.
Leukemia|July 1, 1994
Variable kappa gene rearrangement in lymphoproliferative disorders: an analysis of V kappa gene usage, VJ joining and somatic mutationP K Cannell, P Amlot, M Attard, et al.
Biochemical Society Transactions|May 1, 1997
Recombinant RFB4 single-chain immunotoxin that is cytotoxic towards CD22-positive cellsE Mansfield, M F Chiron, P Amlot, et al.
International Journal of Cancer|September 30, 1991
Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in miceA Engert, G Martin, P Amlot, et al.
Journal of Clinical & Laboratory Immunology|September 1, 1984
A single step radial immunodiffusion (RID) method for the quantitation of monomeric IgMR J Coughlan, A Faith, G S Panayi, et al.
The New England Journal of Medicine|December 1, 1983
Case 15-1983: Hodgkin's disease and focal glomerulosclerosisM Phillips, G H Neild, J S Cameron, et al.
Clinical and Laboratory Haematology|October 16, 2004
Subacute immune response to primary EBV infection leading to post-transplant lymphoproliferative disease in a renal transplant patientS Leaver, P Amlot, R Thuraisingham, et al.
Pageof 5